Skip to main content

CuraSen Therapeutics

San Carlos, United States

CuraSen Therapeutics is a biopharmaceutical company that develops orphan drugs to treat neurodegenerative diseases

$5.8M raised
Sep 2024
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about CuraSen Therapeutics

How much funding has CuraSen Therapeutics raised?
CuraSen Therapeutics has raised $5.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2024.
Who are CuraSen Therapeutics's investors?
CuraSen Therapeutics's investors include Longitude Capital, Pappas Capital, Alta Partners, Johnson & Johnson Innovation – JJDC, New Leaf Venture Partners.
Where is CuraSen Therapeutics headquartered?
CuraSen Therapeutics is headquartered in San Carlos, United States.
What does CuraSen Therapeutics do?
CuraSen Therapeutics is a biopharmaceutical company that develops orphan drugs to treat neurodegenerative diseases
What stage is CuraSen Therapeutics at?
CuraSen Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"CuraSen Therapeutics — Funding & Investors." VCBacked, September 18, 2024, https://www.vcbacked.co/company/curasen-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2024). CuraSen Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/curasen-therapeutics
Wikipedia (cite web)
{{cite web |title=CuraSen Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/curasen-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .